Digest Network Come funziona
Network
/
Società
Sp
Non verificato

Spruce Biosciences, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

34 comunicati stampa

Guarda tutti i comunicati
08/06/2026
Eventi
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
28/05/2026
Web e Social Network
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Web e Social Network
Fiere
Eventi
Spruce Biosciences to Participate in Upcoming Conferences in June
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
13/05/2026
Mercato azionario
Biotecnologia
Igiene alimentare
Salute
Sanità
Comunicazione
Farmaceutica
Scienza
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
04/05/2026
Mercato del lavoro
Finanza
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
21/04/2026
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
20/04/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
09/03/2026
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
09/03/2026
Mercato del lavoro
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0
02/03/2026
Web e Social Network
Eventi
Salute
Scienza
Farmaceutica
Biotecnologia
Spruce Biosciences to Present at Upcoming Investor Conferences in March
Fonte
Spruce Biosciences, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0